Nemaura (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced interim results from its metabolic health program. According to the update, the primary objective of the study was to establish whether a metabolic program with a daily wear CGM worn twice … Continue reading InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Interim Results from Its Miboko Program